Asset Manager

Updated:

Element Biosciences

Element Biosciences offers the AVITI benchtop sequencing platform. The system supports progression of scientific research from inquiry to insight.

Element Biosciences

Element Biosciences offers the AVITI benchtop sequencing platform. The system supports progression of scientific research from inquiry to insight. Results extend to tangible applications outside the laboratory.

General information

Firm type

Asset Manager

Year founded

2017

Location

Region

North America

Country

United States

City

San Diego

Corporate office

10055 Barnes Canyon Road Suite 100, San Diego, CA 92121, United States

Sector focus

Genomics & MultiomicsLife Sciences ToolsBiotech

Frequently asked questions

Who founded Element Biosciences?

Element was founded in July 2017 by a team of industry veterans from the genomics sector, according to the firm's website. The company does not publicly list individual founder names.

What products does Element Biosciences sell?

Element's primary products are the AVITI benchtop sequencing platform and the AVITI24 multiomic system, which performs RNA, protein, and morphology detection on a single integrated platform. The firm also offers chemistry and software workflows, including its Avidite Base Chemistry (ABC) and Direct In Sample Sequencing (DISS) protocols.

How does Element Biosciences' technology differ from Illumina's?

Element claims its Avidite Base Chemistry produces higher accuracy data with lower duplication rates compared to competing sequencers, per testimonials from Jumpcode Genomics and Gencove. The AVITI24 platform also integrates sequencing with spatial imaging and subcellular co-detection, a capability Element says is unique to its platform.

Is Element Biosciences publicly traded?

No, Element Biosciences is a privately held company. Its capital structure and ownership are not publicly disclosed. The firm is not listed on any stock exchange.

Who are Element's prominent customers?

The firm's website cites deployments at the Broad Institute, Google Health Genomics, 10x Genomics, and Jumpcode Genomics, among others. It states its technology has been used in over 400 publications across 40-plus countries.

Where is Element Biosciences headquartered?

Element's headquarters is located at 10055 Barnes Canyon Road, Suite 100, San Diego, CA 92121, United States, as listed on its website.

What investment strategy does Element Biosciences follow?

As a product company, Element does not deploy external capital for private investments. It generates revenue through the sale of sequencing instruments, consumables, and software, and reinvests in R&D and commercial expansion.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More San Diego Asset Manager profiles